WEKO3
アイテム
{"_buckets": {"deposit": "2243ecd3-7315-4e61-a573-c9de3d474313"}, "_deposit": {"created_by": 3, "id": "1883", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "1883"}, "status": "published"}, "_oai": {"id": "oai:air.repo.nii.ac.jp:00001883", "sets": ["916"]}, "author_link": ["6968", "6964", "6972", "6966", "6965", "6967", "6969", "6970", "6971"], "item_10001_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2012-09-28", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "26", "bibliographicPageStart": "19", "bibliographicVolumeNumber": "39", "bibliographic_titles": [{"bibliographic_title": "秋田医学"}]}]}, "item_10001_description_5": {"attribute_name": "内容記述(抄録)", "attribute_value_mlt": [{"subitem_description": "We evaluated the treatment outcomes of chemoradiotherapy for patients with unresectable advanced thoracic esophageal cancer. In total, 103 patients (99 men and 4 women) with unresectable cancer (stage IVA) were treated with chemoradiotherapy between April 2003 and December 2009. They ranged in age from 48 to 89 years, with a median age of 68 years. Two courses of chemotherapy (cisplatin[CDDP] 40 mg/m^2 on Days 1 and 8 plus 5-fluorouracil[5-FU] 400 mg/m^2 on Days 1 through 5 and on Days 8 through 12) and radiotherapy at doses of 59.4 to 66 Gy were administered. The mean follow-up period was 15.3 months (range, 2-88 months). The median overall survival was 13.9 months. The 2-year survival rate was 33.1% and the 3-year survival rate 17.0%. Complete response (CR) was obtained in 18 patients (17.5%). Nine of the 18 patients with CR developed recurrence. Severe hematological toxicities occurred, but were tolerable.", "subitem_description_type": "Other"}]}, "item_10001_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "秋田医学会"}]}, "item_10001_source_id_11": {"attribute_name": "NCID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00009294", "subitem_source_identifier_type": "NCID"}]}, "item_10001_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "03866106", "subitem_source_identifier_type": "ISSN"}]}, "item_10001_version_type_20": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Anbai, Akira"}], "nameIdentifiers": [{"nameIdentifier": "6964", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Koga, Makoto"}], "nameIdentifiers": [{"nameIdentifier": "6965", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Motoyama, Satoru"}], "nameIdentifiers": [{"nameIdentifier": "6966", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sato, Yusuke"}], "nameIdentifiers": [{"nameIdentifier": "6967", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Jin, Mario"}], "nameIdentifiers": [{"nameIdentifier": "6968", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Matsuhashi, Tamotsu"}], "nameIdentifiers": [{"nameIdentifier": "6969", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shibata, Hiroyuki"}], "nameIdentifiers": [{"nameIdentifier": "6970", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ohtsuka, Kazunori"}], "nameIdentifiers": [{"nameIdentifier": "6971", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hashimoto, Manabu"}], "nameIdentifiers": [{"nameIdentifier": "6972", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-02-16"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "aktiai39(19).pdf", "filesize": [{"value": "732.6 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 732600.0, "url": {"label": "aktiai39(19).pdf", "url": "https://air.repo.nii.ac.jp/record/1883/files/aktiai39(19).pdf"}, "version_id": "63bb0c35-a358-4ad3-898e-6fae5b4711c7"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "esophageal cancer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "chemoradiotherapy", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "TREATMENT OUTCOMES OF CHEMORADIOTHERAPY FOR PATIENTS WITH STAGE IVA THORACIC ESOPHAGEAL CANCER AT OUR CENTER", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "TREATMENT OUTCOMES OF CHEMORADIOTHERAPY FOR PATIENTS WITH STAGE IVA THORACIC ESOPHAGEAL CANCER AT OUR CENTER"}]}, "item_type_id": "10001", "owner": "3", "path": ["916"], "permalink_uri": "http://hdl.handle.net/10295/1991", "pubdate": {"attribute_name": "公開日", "attribute_value": "2012-10-21"}, "publish_date": "2012-10-21", "publish_status": "0", "recid": "1883", "relation": {}, "relation_version_is_last": true, "title": ["TREATMENT OUTCOMES OF CHEMORADIOTHERAPY FOR PATIENTS WITH STAGE IVA THORACIC ESOPHAGEAL CANCER AT OUR CENTER"], "weko_shared_id": 3}
TREATMENT OUTCOMES OF CHEMORADIOTHERAPY FOR PATIENTS WITH STAGE IVA THORACIC ESOPHAGEAL CANCER AT OUR CENTER
http://hdl.handle.net/10295/1991
http://hdl.handle.net/10295/19917be66ab2-05f3-497b-ba5e-aae64585b99b
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2012-10-21 | |||||
タイトル | ||||||
タイトル | TREATMENT OUTCOMES OF CHEMORADIOTHERAPY FOR PATIENTS WITH STAGE IVA THORACIC ESOPHAGEAL CANCER AT OUR CENTER | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | esophageal cancer | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | chemoradiotherapy | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Anbai, Akira
× Anbai, Akira× Koga, Makoto× Motoyama, Satoru× Sato, Yusuke× Jin, Mario× Matsuhashi, Tamotsu× Shibata, Hiroyuki× Ohtsuka, Kazunori× Hashimoto, Manabu |
|||||
内容記述(抄録) | ||||||
内容記述タイプ | Other | |||||
内容記述 | We evaluated the treatment outcomes of chemoradiotherapy for patients with unresectable advanced thoracic esophageal cancer. In total, 103 patients (99 men and 4 women) with unresectable cancer (stage IVA) were treated with chemoradiotherapy between April 2003 and December 2009. They ranged in age from 48 to 89 years, with a median age of 68 years. Two courses of chemotherapy (cisplatin[CDDP] 40 mg/m^2 on Days 1 and 8 plus 5-fluorouracil[5-FU] 400 mg/m^2 on Days 1 through 5 and on Days 8 through 12) and radiotherapy at doses of 59.4 to 66 Gy were administered. The mean follow-up period was 15.3 months (range, 2-88 months). The median overall survival was 13.9 months. The 2-year survival rate was 33.1% and the 3-year survival rate 17.0%. Complete response (CR) was obtained in 18 patients (17.5%). Nine of the 18 patients with CR developed recurrence. Severe hematological toxicities occurred, but were tolerable. | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
書誌情報 |
秋田医学 巻 39, 号 1, p. 19-26, 発行日 2012-09-28 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 03866106 | |||||
NCID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00009294 | |||||
出版者 | ||||||
出版者 | 秋田医学会 |